OOIR: Observatory of International Research

Papers

(The TQCC of Human Psychopharmacology-Clinical and Experimental is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine	22
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans	22
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression	18
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis	14
High‐dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression	13
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships	13
Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings	13
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults	12
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials	12
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates	12
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients	12
Elevated serum levels of TNF‐α, IL‐6, and IL‐18 in chronic methamphetamine users	11
Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial	11
Ayahuasca may help to improve self‐compassion and self‐criticism capacities	11
Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression	10
Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder	10
Effects of Korean red ginseng on human gray matter volume and cognitive function: A voxel‐based morphometry study	9
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis	8
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea	8
Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis	7
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms	7
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological st	7
Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users	7
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs	7
How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z‐hypnotic drugs	6

Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: R	6
Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder	6
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study	5
Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice	5
Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia	5
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder	5
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics	4
Psychopharmacoepidemiology of antidepressant medications among homeless and unstably housed service users in the Veterans Affairs healthcare system	4
An explorative approach to understanding individual differences in driving performance and neurocognition in long‐term benzodiazepine users	4
The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers	4
Can placebo or nocebo pills improve or impair cognition performance?	3
Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐m	3
Adiponectin predicts poor response to antidepressant drugs in major depressive disorder	3
Nx4 attenuated stress‐induced activity of the anterior cingulate cortex—A post‐hoc analysis of a randomized placebo‐controlled crossover trial	3
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant	3
Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits	3
Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial	3
Could N‐acetylcysteine improve the safety of clozapine?	3